Study to Evaluate the Efficacy and Safety of GX-E2 in the Anemic Patients Diagnosed With Chronic Kidney Disease (CKD)

NCT02044653 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

257

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia
Chronic Kidney Disease

Interventions

DRUG: GX-E2
DRUG: GX-E2
DRUG: GX-E2
DRUG: NESP
DRUG: MIRCERA

Sponsor

Genexine, Inc.